Impact of dermatologic adverse reactions on QOL in oncologic patients: results from a single-center prospective study

• Hauptverfasser: Barbu Maria Alexandra (Verfasst von), Niţipir Cornelia (Verfasst von), Voiosu Theodor (Verfasst von), Giurcăneanu Călin (Verfasst von)
• Format: Buch
• Veröffentlicht: Sciendo, 2018-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Introduction. Skin toxicity in patients receiving novel therapeutic cancer agents has become a very important marker in determining drug activity, but it can also severely impact their quality of life. About half of the patients receiving this type of oncologic treatment will develop cutaneous react...